APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Biomedical

Compare research editions
View pricing & licenses

Selected research

Industry Research

Artificial Intelligence in Biomedical Industry Research Report 2026

3 July 2026137 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Biomedical Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Biomedical Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Biomedical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Biomedical Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Biomedical Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Biomedical market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Artificial Intelligence in Biomedical market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Artificial Intelligence in Biomedical market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Artificial Intelligence in Biomedical market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Artificial Intelligence in Biomedical include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation and Novartis AG, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Artificial Intelligence in Biomedical market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Artificial Intelligence in Biomedical.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Artificial Intelligence in Biomedical Market by Company

AstraZeneca

Thales Group

IBM Corp.

ForeSee Medical

Atomwise

Cloud Pharmaceuticals

GNS Healthcare

Microsoft Corporation

Novartis AG

NVIDIA Corporation

Pfizer

Recursion Pharmaceuticals

XtalPi Inc

Aidoc

AliveCor

GE Healthcare

Imagen Technologies

Vuno Inc.

IDx Technologies Inc.

Siemens Healthcare GmbH

Neural Analytics

Artificial Intelligence in Biomedical Segment by Type

Hardware

Software

Artificial Intelligence in Biomedical Segment by Application

Diagnosing Diseases

Developing Drugs

Personalized Treatment

Other

Artificial Intelligence in Biomedical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Biomedical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Biomedical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Biomedical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Artificial Intelligence in Biomedical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2021-2026) Table 7. Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2027-2032) Table 9. Global Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2021-2026) Table 11. Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2027-2032) Table 13. Global Artificial Intelligence in Biomedical Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Artificial Intelligence in Biomedical Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Artificial Intelligence in Biomedical Market Share by Region (2021-2026) Table 16. Global Artificial Intelligence in Biomedical Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Artificial Intelligence in Biomedical Market Share by Region (2027-2032) Table 18. Artificial Intelligence in Biomedical Industry Trends Table 19. Artificial Intelligence in Biomedical Industry Drivers Table 20. Artificial Intelligence in Biomedical Industry Opportunities and Challenges Table 21. Artificial Intelligence in Biomedical Market Restraints Table 22. Global Top Artificial Intelligence in Biomedical Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Artificial Intelligence in Biomedical Revenue Market Share by Players (2021-2026) Table 24. Global Artificial Intelligence in Biomedical Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Artificial Intelligence in Biomedical, Headquarters and Area Served Table 26. Global Artificial Intelligence in Biomedical Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Artificial Intelligence in Biomedical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Artificial Intelligence in Biomedical Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Artificial Intelligence in Biomedical Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Artificial Intelligence in Biomedical Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Artificial Intelligence in Biomedical Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Artificial Intelligence in Biomedical Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2027-2032) & (US$ Million) Table 45. AstraZeneca Company Information Table 46. AstraZeneca Business Overview Table 47. AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 48. AstraZeneca Artificial Intelligence in Biomedical Product Portfolio Table 49. AstraZeneca Recent Developments Table 50. Thales Group Company Information Table 51. Thales Group Business Overview Table 52. Thales Group Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 53. Thales Group Artificial Intelligence in Biomedical Product Portfolio Table 54. Thales Group Recent Developments Table 55. IBM Corp. Company Information Table 56. IBM Corp. Business Overview Table 57. IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 58. IBM Corp. Artificial Intelligence in Biomedical Product Portfolio Table 59. IBM Corp. Recent Developments Table 60. ForeSee Medical Company Information Table 61. ForeSee Medical Business Overview Table 62. ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 63. ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio Table 64. ForeSee Medical Recent Developments Table 65. Atomwise Company Information Table 66. Atomwise Business Overview Table 67. Atomwise Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 68. Atomwise Artificial Intelligence in Biomedical Product Portfolio Table 69. Atomwise Recent Developments Table 70. Cloud Pharmaceuticals Company Information Table 71. Cloud Pharmaceuticals Business Overview Table 72. Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 73. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 74. Cloud Pharmaceuticals Recent Developments Table 75. GNS Healthcare Company Information Table 76. GNS Healthcare Business Overview Table 77. GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 78. GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 79. GNS Healthcare Recent Developments Table 80. Microsoft Corporation Company Information Table 81. Microsoft Corporation Business Overview Table 82. Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 83. Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio Table 84. Microsoft Corporation Recent Developments Table 85. Novartis AG Company Information Table 86. Novartis AG Business Overview Table 87. Novartis AG Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 88. Novartis AG Artificial Intelligence in Biomedical Product Portfolio Table 89. Novartis AG Recent Developments Table 90. NVIDIA Corporation Company Information Table 91. NVIDIA Corporation Business Overview Table 92. NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 93. NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio Table 94. NVIDIA Corporation Recent Developments Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 98. Pfizer Artificial Intelligence in Biomedical Product Portfolio Table 99. Pfizer Recent Developments Table 100. Recursion Pharmaceuticals Company Information Table 101. Recursion Pharmaceuticals Business Overview Table 102. Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 103. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 104. Recursion Pharmaceuticals Recent Developments Table 105. XtalPi Inc Company Information Table 106. XtalPi Inc Business Overview Table 107. XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 108. XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio Table 109. XtalPi Inc Recent Developments Table 110. Aidoc Company Information Table 111. Aidoc Business Overview Table 112. Aidoc Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 113. Aidoc Artificial Intelligence in Biomedical Product Portfolio Table 114. Aidoc Recent Developments Table 115. AliveCor Company Information Table 116. AliveCor Business Overview Table 117. AliveCor Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 118. AliveCor Artificial Intelligence in Biomedical Product Portfolio Table 119. AliveCor Recent Developments Table 120. GE Healthcare Company Information Table 121. GE Healthcare Business Overview Table 122. GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 123. GE Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 124. GE Healthcare Recent Developments Table 125. Imagen Technologies Company Information Table 126. Imagen Technologies Business Overview Table 127. Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 128. Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio Table 129. Imagen Technologies Recent Developments Table 130. Vuno Inc. Company Information Table 131. Vuno Inc. Business Overview Table 132. Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 133. Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio Table 134. Vuno Inc. Recent Developments Table 135. IDx Technologies Inc. Company Information Table 136. IDx Technologies Inc. Business Overview Table 137. IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 138. IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio Table 139. IDx Technologies Inc. Recent Developments Table 140. Siemens Healthcare GmbH Company Information Table 141. Siemens Healthcare GmbH Business Overview Table 142. Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 143. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio Table 144. Siemens Healthcare GmbH Recent Developments Table 145. Neural Analytics Company Information Table 146. Neural Analytics Business Overview Table 147. Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (2021-2026) & (US$ Million) Table 148. Neural Analytics Artificial Intelligence in Biomedical Product Portfolio Table 149. Neural Analytics Recent Developments Table 150. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Artificial Intelligence in Biomedical Product Image Figure 5. Global Artificial Intelligence in Biomedical Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Artificial Intelligence in Biomedical Market Share by Type: 2025 VS 2032 Figure 7. Hardware Product Figure 8. Software Product Figure 9. Global Artificial Intelligence in Biomedical Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Artificial Intelligence in Biomedical Market Share by Application: 2025 VS 2032 Figure 11. Diagnosing Diseases Product Figure 12. Developing Drugs Product Figure 13. Personalized Treatment Product Figure 14. Other Product Figure 15. Global Artificial Intelligence in Biomedical Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Artificial Intelligence in Biomedical Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Artificial Intelligence in Biomedical Market Share by Region: 2025 VS 2032 Figure 18. Global Artificial Intelligence in Biomedical Market Share by Players in 2025 Figure 19. Global Artificial Intelligence in Biomedical Manufacturers Established Date Figure 20. Global Top 5 and 10 Artificial Intelligence in Biomedical Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 24. United States Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 27. Europe Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 29. Germany Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 39. China Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 44. Australia Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 49. Brazil Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Artificial Intelligence in Biomedical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. AstraZeneca Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 55. Thales Group Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 56. IBM Corp. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 57. ForeSee Medical Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 58. Atomwise Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 59. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 60. GNS Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 61. Microsoft Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 62. Novartis AG Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 63. NVIDIA Corporation Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 64. Pfizer Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 65. Recursion Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 66. XtalPi Inc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 67. Aidoc Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 68. AliveCor Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 69. GE Healthcare Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 70. Imagen Technologies Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 71. Vuno Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 72. IDx Technologies Inc. Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 73. Siemens Healthcare GmbH Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026) Figure 74. Neural Analytics Revenue Growth Rate in Artificial Intelligence in Biomedical Business (2021-2026)

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Diagnosing Diseases
  • Developing Drugs
  • Personalized Treatment
  • Other
Companies covered
  • AstraZeneca
  • Thales Group
  • IBM Corp.
  • ForeSee Medical
  • Atomwise
  • Cloud Pharmaceuticals
  • GNS Healthcare
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Pfizer
  • Recursion Pharmaceuticals
  • XtalPi Inc
  • Aidoc
  • AliveCor
  • GE Healthcare
  • Imagen Technologies
  • Vuno Inc.
  • IDx Technologies Inc.
  • Siemens Healthcare GmbH
  • Neural Analytics

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Artificial Intelligence in Biomedical by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Hardware
  5. 2.2.3 Software
  6. 2.3 Artificial Intelligence in Biomedical by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Diagnosing Diseases
  9. 2.3.3 Developing Drugs
  10. 2.3.4 Personalized Treatment
  11. 2.3.5 Other
  12. 2.4 Assumptions and Limitations
3 Artificial Intelligence in Biomedical Breakdown Data by Type
  1. 3.1 Global Artificial Intelligence in Biomedical Historic Market Size by Type (2021-2026)
  2. 3.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Type (2027-2032)
4 Artificial Intelligence in Biomedical Breakdown Data by Application
  1. 4.1 Global Artificial Intelligence in Biomedical Historic Market Size by Application (2021-2026)
  2. 4.2 Global Artificial Intelligence in Biomedical Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Artificial Intelligence in Biomedical Market Perspective (2021-2032)
  2. 5.2 Global Artificial Intelligence in Biomedical Growth Trends by Region
  3. 5.2.1 Global Artificial Intelligence in Biomedical Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Artificial Intelligence in Biomedical Historic Market Size by Region (2021-2026)
  5. 5.2.3 Artificial Intelligence in Biomedical Forecasted Market Size by Region (2027-2032)
  6. 5.3 Artificial Intelligence in Biomedical Market Dynamics
  7. 5.3.1 Artificial Intelligence in Biomedical Industry Trends
  8. 5.3.2 Artificial Intelligence in Biomedical Market Drivers
  9. 5.3.3 Artificial Intelligence in Biomedical Market Challenges
  10. 5.3.4 Artificial Intelligence in Biomedical Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Artificial Intelligence in Biomedical Players by Revenue
  2. 6.1.1 Global Top Artificial Intelligence in Biomedical Players by Revenue (2021-2026)
  3. 6.1.2 Global Artificial Intelligence in Biomedical Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Artificial Intelligence in Biomedical Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Artificial Intelligence in Biomedical Head Office and Area Served
  6. 6.4 Global Artificial Intelligence in Biomedical Players, Product Type & Application
  7. 6.5 Global Artificial Intelligence in Biomedical Manufacturers Established Date
  8. 6.6 Global Artificial Intelligence in Biomedical Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 7.2 North America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  4. 7.4 North America Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 8.2 Europe Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  4. 8.4 Europe Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 9.2 Asia-Pacific Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 10.2 South America Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  4. 10.4 South America Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 11.2 Middle East & Africa Artificial Intelligence in Biomedical Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 AstraZeneca
  2. 12.1.1 AstraZeneca Company Information
  3. 12.1.2 AstraZeneca Business Overview
  4. 12.1.3 AstraZeneca Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  5. 12.1.4 AstraZeneca Artificial Intelligence in Biomedical Product Portfolio
  6. 12.1.5 AstraZeneca Recent Developments
  7. 12.2 Thales Group
  8. 12.2.1 Thales Group Company Information
  9. 12.2.2 Thales Group Business Overview
  10. 12.2.3 Thales Group Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  11. 12.2.4 Thales Group Artificial Intelligence in Biomedical Product Portfolio
  12. 12.2.5 Thales Group Recent Developments
  13. 12.3 IBM Corp.
  14. 12.3.1 IBM Corp. Company Information
  15. 12.3.2 IBM Corp. Business Overview
  16. 12.3.3 IBM Corp. Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  17. 12.3.4 IBM Corp. Artificial Intelligence in Biomedical Product Portfolio
  18. 12.3.5 IBM Corp. Recent Developments
  19. 12.4 ForeSee Medical
  20. 12.4.1 ForeSee Medical Company Information
  21. 12.4.2 ForeSee Medical Business Overview
  22. 12.4.3 ForeSee Medical Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  23. 12.4.4 ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio
  24. 12.4.5 ForeSee Medical Recent Developments
  25. 12.5 Atomwise
  26. 12.5.1 Atomwise Company Information
  27. 12.5.2 Atomwise Business Overview
  28. 12.5.3 Atomwise Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  29. 12.5.4 Atomwise Artificial Intelligence in Biomedical Product Portfolio
  30. 12.5.5 Atomwise Recent Developments
  31. 12.6 Cloud Pharmaceuticals
  32. 12.6.1 Cloud Pharmaceuticals Company Information
  33. 12.6.2 Cloud Pharmaceuticals Business Overview
  34. 12.6.3 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  35. 12.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  36. 12.6.5 Cloud Pharmaceuticals Recent Developments
  37. 12.7 GNS Healthcare
  38. 12.7.1 GNS Healthcare Company Information
  39. 12.7.2 GNS Healthcare Business Overview
  40. 12.7.3 GNS Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  41. 12.7.4 GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio
  42. 12.7.5 GNS Healthcare Recent Developments
  43. 12.8 Microsoft Corporation
  44. 12.8.1 Microsoft Corporation Company Information
  45. 12.8.2 Microsoft Corporation Business Overview
  46. 12.8.3 Microsoft Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  47. 12.8.4 Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio
  48. 12.8.5 Microsoft Corporation Recent Developments
  49. 12.9 Novartis AG
  50. 12.9.1 Novartis AG Company Information
  51. 12.9.2 Novartis AG Business Overview
  52. 12.9.3 Novartis AG Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  53. 12.9.4 Novartis AG Artificial Intelligence in Biomedical Product Portfolio
  54. 12.9.5 Novartis AG Recent Developments
  55. 12.10 NVIDIA Corporation
  56. 12.10.1 NVIDIA Corporation Company Information
  57. 12.10.2 NVIDIA Corporation Business Overview
  58. 12.10.3 NVIDIA Corporation Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  59. 12.10.4 NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio
  60. 12.10.5 NVIDIA Corporation Recent Developments
  61. 12.11 Pfizer
  62. 12.11.1 Pfizer Company Information
  63. 12.11.2 Pfizer Business Overview
  64. 12.11.3 Pfizer Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  65. 12.11.4 Pfizer Artificial Intelligence in Biomedical Product Portfolio
  66. 12.11.5 Pfizer Recent Developments
  67. 12.12 Recursion Pharmaceuticals
  68. 12.12.1 Recursion Pharmaceuticals Company Information
  69. 12.12.2 Recursion Pharmaceuticals Business Overview
  70. 12.12.3 Recursion Pharmaceuticals Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  71. 12.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  72. 12.12.5 Recursion Pharmaceuticals Recent Developments
  73. 12.13 XtalPi Inc
  74. 12.13.1 XtalPi Inc Company Information
  75. 12.13.2 XtalPi Inc Business Overview
  76. 12.13.3 XtalPi Inc Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  77. 12.13.4 XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio
  78. 12.13.5 XtalPi Inc Recent Developments
  79. 12.14 Aidoc
  80. 12.14.1 Aidoc Company Information
  81. 12.14.2 Aidoc Business Overview
  82. 12.14.3 Aidoc Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  83. 12.14.4 Aidoc Artificial Intelligence in Biomedical Product Portfolio
  84. 12.14.5 Aidoc Recent Developments
  85. 12.15 AliveCor
  86. 12.15.1 AliveCor Company Information
  87. 12.15.2 AliveCor Business Overview
  88. 12.15.3 AliveCor Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  89. 12.15.4 AliveCor Artificial Intelligence in Biomedical Product Portfolio
  90. 12.15.5 AliveCor Recent Developments
  91. 12.16 GE Healthcare
  92. 12.16.1 GE Healthcare Company Information
  93. 12.16.2 GE Healthcare Business Overview
  94. 12.16.3 GE Healthcare Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  95. 12.16.4 GE Healthcare Artificial Intelligence in Biomedical Product Portfolio
  96. 12.16.5 GE Healthcare Recent Developments
  97. 12.17 Imagen Technologies
  98. 12.17.1 Imagen Technologies Company Information
  99. 12.17.2 Imagen Technologies Business Overview
  100. 12.17.3 Imagen Technologies Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  101. 12.17.4 Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio
  102. 12.17.5 Imagen Technologies Recent Developments
  103. 12.18 Vuno Inc.
  104. 12.18.1 Vuno Inc. Company Information
  105. 12.18.2 Vuno Inc. Business Overview
  106. 12.18.3 Vuno Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  107. 12.18.4 Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio
  108. 12.18.5 Vuno Inc. Recent Developments
  109. 12.19 IDx Technologies Inc.
  110. 12.19.1 IDx Technologies Inc. Company Information
  111. 12.19.2 IDx Technologies Inc. Business Overview
  112. 12.19.3 IDx Technologies Inc. Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  113. 12.19.4 IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio
  114. 12.19.5 IDx Technologies Inc. Recent Developments
  115. 12.20 Siemens Healthcare GmbH
  116. 12.20.1 Siemens Healthcare GmbH Company Information
  117. 12.20.2 Siemens Healthcare GmbH Business Overview
  118. 12.20.3 Siemens Healthcare GmbH Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  119. 12.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio
  120. 12.20.5 Siemens Healthcare GmbH Recent Developments
  121. 12.21 Neural Analytics
  122. 12.21.1 Neural Analytics Company Information
  123. 12.21.2 Neural Analytics Business Overview
  124. 12.21.3 Neural Analytics Revenue in Artificial Intelligence in Biomedical Business (2021-2026)
  125. 12.21.4 Neural Analytics Artificial Intelligence in Biomedical Product Portfolio
  126. 12.21.5 Neural Analytics Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst